Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition - Reuters
Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOU3c5a1lGUmk5eEU2TEMzYXhydlcwNXVfdGJ5OFM0cWRJbkk2VWpPRW1zY0hyZ0dwMF9ZX2xfNE9zR3NyNEJfVmJVRFp4X3FVRDZoQU83RDUyc1pwQjBxS2gtM1RjVTg3VE1zbWZtME9ZSEdKcW9sRmxqWlUwRGlRVXEzSE00WHRMS0FseUVwZEZaYkdHSjZpTnpsS21ncHV4Skc5T2JhWWViYld6Y0NtbGNoajJUV2pSMjdWaExxcEN6MFA2M1Bnd1FvRDNEdw?oc=5" target="_blank">Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMChina, EU strike deal to halve Chinese hybrid exports - Reuters
China, EU strike deal to halve Chinese hybrid exports Reuters
October 9, 2026 at 04:58 PMChina's tax crackdown piles pressure on luxury brands as US spending falters - Reuters
China's tax crackdown piles pressure on luxury brands as US spending falters Reuters
October 9, 2026 at 05:03 AMEuropean industry groups call for urgent EU action on China trade - Reuters
European industry groups call for urgent EU action on China trade Reuters
October 8, 2026 at 09:44 PM